Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers

Clinica Chimica Acta

Volumn 353, Issue 1-2, 2005, Pages 201-203

  Linthorst, Gabor E ^a   Vedder, Anouk C ^a   Aerts, Johannes M F G ^a   Hollak, Carla E M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FABRY DISEASE; FEMALE; GENETIC SCREENING; HETEROZYGOTE; HUMAN; MALE; MEDICAL DOCUMENTATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

EID: 13444267466     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.10.019     Document Type: Article

References (14)

1. J.A. Kint Fabry's disease: alpha-galactosidase deficiency Science 167 1970 1268 1269
2. R.J. Desnick, Y.A. Ioannou, and M.E. Eng α-Galactosidase a deficiency: Fabry disease C.R. Scriver A.L. Beaudet W.S. Sly D. Valle 8th ed. The metabolic and molecular bases of inherited disease vol. 3 2001 McGraw-Hill New York 3733 3774
3. P.J. Meikle, J.J. Hopwood, A.E. Clague, and W.F. Carey Prevalence of lysosomal storage disorders JAMA 281 1999 249 254
4. B.J. Poorthuis, R.A. Wevers, W.J. Kleijer, J.E. Groener, J.C. de Jong, and S. van Weely The frequency of lysosomal storage diseases in The Netherlands Hum. Genet. 105 1999 151 156
5. C.M. Eng, N. Guffon, W.R. Wilcox, D.P. Germain, P. Lee, and S. Waldek Safety and efficacy of recombinant human α-galactosidase A replacement therapy in Fabry's disease N. Engl. J. Med. 345 2001 9 16
6. S. Nakao, C. Kodama, T. Takenaka, A. Tanaka, Y. Yasumoto, and A. Yoshida Fabry disease: Detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype Kidney Int. 64 2003 801 807
7. K. Utsumi, R. Kase, T. Takata, H. Sakuraba, N. Matsui, and H. Saito Fabry disease in patients receiving maintenance dialysis Clin. Exp. Nephrol. 4 1999 49 51
8. G.E. Linthorst, C.E.M. Hollak, J.C. Korevaar, J.G. van Manen, J.M.F.G. Aerts, and E.W. Boeschoten {alpha}-Galactosidase A deficiency in Dutch patients on dialysis: a critical appraisal of screening for Fabry disease Nephrol. Dial. Transplant. 18 2003 1581 1584
9. B. Sachdev, T. Takenaka, H. Teraguchi, C. Tei, P. Lee, and W.J. McKenna Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy Circulation 105 2002 1407 1411
10. S. Nakao, T. Takenaka, M. Maeda, C. Kodama, A. Tanaka, and M. Tahara An atypical variant of Fabry's disease in men with left ventricular hypertrophy N. Engl. J. Med. 333 1995 288 293
11. N.A. Chamoles, M. Blanco, and D. Gaggioli Fabry disease: enzymatic diagnosis in dried blood spots on filter paper Clin. Chim. Acta 308 2001 195 196
12. M. Spada, and S. Pagliardini Screening for Fabry disease in end-stage nephropaties J. Inherit. Metab. Dis. 25 Suppl. I 2002 113 [Ref Type: Abstract]
13. P. Kotanko, R. Kramar, D. Devrnja, E. Paschke, T. VoIgtlander, and M. Auinger Results of a nationwide screening for Anderson-Fabry disease among dialysis patients J. Am. Soc. Nephrol. 15 2004 1323 1329
14. R.J. Desnick, K.Y. Allen, S.J. Desnick, M.K. Raman, R.W. Bernlohr, and W. Krivit Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes J. Lab. Clin. Med. 81 1973 157 171